Cargando…
Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis
OBJECTIVE: No efficacious treatments exist to improve or prolong bulbar functions of speech and swallowing in persons with amyotrophic lateral sclerosis (pALS). This study evaluated the short‐term impact of dextromethorphan/quinidine (DMQ) treatment on speech and swallowing function in pALS. METHODS...
Autores principales: | Tabor Gray, Lauren, Locatelli, Eduardo, Vasilopoulos, Terrie, Wymer, James, Plowman, Emily K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424659/ https://www.ncbi.nlm.nih.gov/pubmed/37265174 http://dx.doi.org/10.1002/acn3.51821 |
Ejemplares similares
-
Diagnostic utility of the amyotrophic lateral sclerosis Functional Rating Scale—Revised to detect pharyngeal dysphagia in individuals with amyotrophic lateral sclerosis
por: Chapin, Jennifer L., et al.
Publicado: (2020) -
Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis
por: Green, Jordan R., et al.
Publicado: (2018) -
Combined respiratory training in an individual with C9orf72 amyotrophic lateral sclerosis
por: Robison, Raele, et al.
Publicado: (2018) -
Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
por: Khoury, Rita
Publicado: (2021) -
Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
por: Smith, Richard, et al.
Publicado: (2017)